Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-206 Phase III Trial in Active Crohn's Disease
jRCT2080220189Phase 3
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mesalazine in Crohn's disease, sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
mesalazine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080220189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220189.